July 2017 – Kahn Partners, counsel to Diaxonhit on its acquisition of GenBio
Kahn Partners represented Paris-based Diaxonhit in its acquisition of GenBio, a San Diego based medical diagnostic company. Diaxonhit is a company listed on Euronext in Paris. The transaction, which was financed through, was closed in San Diego after a short four-month multi-level negotiation process. The transaction was handled by Kahn Partners’ San Francisco and Washington D.C. offices.